Macimorelin

Also known as: Macrilen, AEZS-130

Growth HormoneFDA APPROVED

Clinical Status

FDA Approved — diagnostic test for adult GH deficiency.

Mechanism of Action

Orally active ghrelin receptor agonist that stimulates GH release from the pituitary. Used as a diagnostic tool — the magnitude of GH response indicates pituitary GH reserve.

Dosing Defaults

Dose

0.5 mg/kg

Frequency

Single diagnostic dose

Administration

Oral solution

Timing

Morning after overnight fast

Food

fasted

Duration

Single use diagnostic

Dose range: 0.5 mg/kg single dose

Overnight fast required for accurate diagnostic result.

Side Effects

•Dysgeusia (taste disturbance)
•Dizziness
•Headache
•Nausea
•Fatigue

Contraindications & Warnings

•Not medical advice
•FDA approved for diagnostic use only

Compare

Compare Macimorelin with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your Macimorelin dose.

Open Calculator

Related Growth Hormone Peptides

Ipamorelin

PHASE 2

Growth Hormone

Selective GH secretagogue. Considered one of the safest GHRPs.

CJC-1295

PHASE 2

Growth Hormone

Synthetic GHRH analog that stimulates GH release from the pituitary.

CJC-1295 DAC

PHASE 2

Growth Hormone

Long-acting version of CJC-1295 with extended half-life via albumin binding.

Tesamorelin

FDA APPROVED

Growth Hormone

FDA-approved GHRH analog for visceral fat reduction in HIV lipodystrophy.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.